URCN | Unité de Recherche Clinique de NANORO

Switch to desktop Register Login

Publications 2017 (23 articles published)

1

Gargano N, Madrid L, Valentini G, D'Alessandro U, Halidou T, Sirima S, Tshefu A, Mtoro A, Gesase S; Eurartesim Dispersible Study Group, Bassat Q. (2017). Efficacy and tolerability outcomes of a phase ii, randomized, open-label, multicenter study of a new water-dispersible pediatric formulation of dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in African infants. Antimicrobial Agents and Chemotherapy. 2017 Dec 21;62(1). pii: e00596-17. doi: 10.1128/AAC.00596-17.

 

 2

Ruizendaal E, Schallig HDFH, Bradley J, Traore-Coulibaly M, Lompo P, d'Alessandro U, Scott S, Njie F, Zango SH, Sawadogo O, de Jong MD, Tinto H, Mens PF. (2017).Interleukin-10 and soluble tumor necrosis factor receptor II are potential biomarkers of Plasmodium falciparum infections in pregnant women: a case-control study from Nanoro, Burkina Faso. Biomarker Research. 2017 Dec 13;5:34. doi: 10.1186/s40364-017-0114-7. eCollection 2017.

 

3

Sorgho H, Da O, Rouamba T, Savadogo B, Tinto H, Ouedraogo J-B. (2017). Schistosoma mansoni infection and hematological profile in an endemic foci in Western Burkina Faso. African Journal of Parasitology Research,4 (10), 264-270.

 

 4

Brabin L, Roberts SA, Gies S, Nelson A, Diallo S, Stewart CJ, Kazienga A, Birtles J, Ouedraogo S, Claeys Y, Tinto H, d'Alessandro U, Faragher EB, Brabin B. (2017). Effects of long-term weekly iron and folic acid supplementation on lower genital tract infection - a double blind, randomised controlled trial in Burkina Faso. BMC Medicine. 2017 Nov 23;15(1):206. doi: 10.1186/s12916-017-0967-5.

 

 5

Bihoun B, Zango SH, Traoré-Coulibaly M, Rouamba T, Zemba D, Tahita MC, Yarga S, Kabore B, Lompo P, Valea I, Samadoulougou SO, Ravinetto R, Van-Geertruyden J-P, D’Alessandro U, Tinto H, Robert A. (2017).Low birth weight and prematurity in teenage mothers in rural areas of Burkina Faso. Journal of Pregnancy and Child Health, 4. 344. doi: 10.4172/2376-127X.1000344

 

 6

Drakeley C, Abdulla S, Agnandji ST, Fernandes JF, Kremsner P, Lell B, Mewono L, Bache BE, Mihayo MG, Juma O, Tanner M, Tahita MC, Tinto H, Diallo S, Lompo P, D'Alessandro U, Ogutu B, Otieno L, Otieno S, Otieno W, Oyieko J, Asante KP, Dery DB, Adjei G, Adeniji E, Atibilla D, Owusu-Agyei S, Greenwood B, Gesase S, Lusingu J, Mahende C, Mongi R, Segeja M, Adjei S, Agbenyega T, Agyekum A, Ansong D, Bawa JT, Boateng HO, Dandalo L, Escamilla V, Hoffman I, Maenje P, Martinson F, Carter T, Leboulleux D, Kaslow DC, Usuf E, Pirçon JY, Bahmanyar ER.(2017). Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries.Malaria Journal. 2017 Oct 27;16(1):433. doi: 10.1186/s12936-017-2078-3.

 

 7

Macintyre F, Adoke Y, Tiono AB, Duong TT, Mombo-Ngoma G, Bouyou-Akotet M, Tinto H, Bassat Q, Issifou S, Adamy M, Demarest H, Duparc S, Leroy D, Laurijssens BE, Biguenet S, Kibuuka A, Tshefu AK, Smith M, Foster C, Leipoldt I, Kremsner PG, Phuc BQ, Ouedraogo A, Ramharter M; OZ-Piperaquine Study Group.(2017).A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria.BMC Medicine, 2017 Oct 9;15(1):181. doi: 10.1186/s12916-017-0940-3.

 

8

Ruizendaal E, Schallig HDFH, Scott S, Traore-Coulibaly M, Bradley J, Lompo P, Magloire NH, Traore O, Valea I, Dierickx S, Drabo KM, Pagnoni F, Alessandro U, Tinto H, Mens PF.(2017). Evaluation of malaria screening during pregnancy with rapid diagnostic tests performed by community health workers in Burkina Faso.American Journal of Tropical Medicine and Hygiene. 2017 Oct;97(4):1190-1197. doi: 10.4269/ajtmh.17-0138

 

 9

Ruizendaal E, Tahita MC, Traoré MTinto H, Schallig HDFH, Mens PF. (2017). Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso. Molecular Biochemistry and Parasitology. 2017 Oct; 217:13-15. doi: 10.1016/j.molbiopara.2017.08.003

 

 10

Ruizendaal E, Tahita MC, Traoré MTinto H, Schallig HDFH, Mens PF. (2017). Presence of quintuple dhfr N51, C59, S108 - dhps A437, K540 mutations in Plasmodium falciparum isolates from pregnant women and the general population in Nanoro, Burkina Faso. Molecular Biochemistry and Parasitology. 2017 Oct; 217:13-15. doi: 10.1016/j.molbiopara.2017.08.003

 

 11

Cates JE, Unger HW, Briand V, Fievet N, Valea I, Tinto H, D'Alessandro U, Landis SH, Adu-Afarwuah S, Dewey KG, Ter Kuile FO, Desai M, Dellicour S, Ouma P, Gutman J, Oneko M, Slutsker L, Terlouw DJ, Kariuki S, Ayisi J, Madanitsa M, Mwapasa V, Ashorn P, Maleta K, Mueller I, Stanisic D, Schmiegelow C, Lusingu JPA, van Eijk AM, Bauserman M, Adair L, Cole SR, Westreich D, Meshnick S, Rogerson S.(2017). Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data.PLoS Medicine. 2017 Aug 8;14(8):e1002373. doi: 10.1371/journal.pmed.1002373.

 

 12

Sondo P, Derra K, Diallo Nakanabo S, Tarnagda Z, Kazienga A, Valea I, Sorgho H, Ouédraogo J-B, Guiguemdé TR, Tinto H. (2017). Comparison of effectiveness of two different artemisinin based combination therapies in an area with high seasonal transmission of malaria in Burkina Faso. Annals of Parasitology. 2017, 63(2), 127–130. doi: 10.17420/ap6302.96

 

 13

Kiemde F, Bonko MDA, Tahita MC, Lompo P, Rouamba T, Tinto H, van Hensbroek MB, Mens PF, Schallig HDFH. (2017). Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic test in the context of the presence of non-malaria fevers, prior anti-malarial use and seasonal malaria transmission. Malaria Journal. 2017 Jul 20;16(1):294. doi: 10.1186/s12936-017-1941-6.

 

 14

Guiraud I, Post A, Diallo SN, Lompo P, Maltha J, Thriemer K, Tahita CM, Ley B, Derra K, Bottieau E, Kazienga A, Schurmans C, Ravinetto R, Rouamba E, Van Griensven J, Bertrand S, Tinto H, Jacobs J. (2017). Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso. PLoS One. 2017 Jul 10;12(7):e0178577. doi: 10.1371/journal.pone.0178577

 

 15

Ravinetto R, Tinto H, Diro E, Okebe J, Mahendradhata Y, Rijal S, Gotuzzo E, Lutumba P, Nahum A, De Nys K, Casteels M, Boelaert M. (2017). It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North-South collaborative trials. BMJ Global Health. 2016 Nov 16;1(3):e000122. doi: 10.1136/bmjgh-2016-000122.

 

 16

Natama HM, Ouedraogo DF, Sorgho H, Rovira-Vallbona E, Serra-Casas E, Somé MA, Coulibaly-Traoré M, Mens PF, Kestens L, Tinto H, Rosanas-Urgell A. (2017). Diagnosing congenital malaria in a high-transmission setting: clinical relevance and usefulness of P. falciparum HRP2-based testing. Scientific Reports, 2017 May 18;7(1):2080. doi: 10.1038/s41598-017-02173-6.

 

 17

Held J, Supan C, Salazar CLO, Tinto H, Bonkian LN, Nahum A, Sié A, Abdulla S, Cantalloube C, Djeriou E, Bouyou-Akotet M, Ogutu B, Mordmüller B, Kreidenweiss A, Siribie M, Sirima SB, Kremsner PG. (2017). Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients. Malaria Journal. 2017 May 4;16(1):188. doi: 10.1186/s12936-017-1832-x.

 

 18

Greenwood B, Dicko A, Sagara I, Zongo I, Tinto H, Cairns M, Kuepfer I, Milligan P, Ouedraogo JB, Doumbo O, Chandramohan D. (2017). Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine. Malaria Journal. 2017 May 2;16(1):182. doi: 10.1186/s12936-017-1841-9

 

 19

Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Manyando C, Rulisa S, Desai M, Ouma P, Oneko M, Vala A, Rupérez M, Macete E, Menéndez C, Nakanabo-Diallo S, Kazienga A, Valéa I, Calip G, Augusto O, Genton B, Njunju EM, Moore KA, d'Alessandro U, Nosten F, Ter Kuile F, Stergachis A. (2017). First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies. PLoS Medicine. 2017 May 2;14(5):e1002290. doi: 10.1371/journal.pmed.1002290. eCollection 2017 May.

 

 20

Ruizendaal E, Tahita MC, Geskus RB, Versteeg I, Scott S, d'Alessandro U, Lompo P, Derra K, Traore-Coulibaly M, de Jong MD, Schallig HDFH, Tinto H, Mens PF. (2017). Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso. Malaria Journal 2017 Apr 28;16(1):179. doi: 10.1186/s12936-017-1831-y.

 

 21

Gómez-Olivé FX, Ali SA, Made F, Kyobutungi C, Nonterah E, Micklesfield L, Alberts M, Boua R, Hazelhurst S, Debpuur C, Mashinya F, Dikotope S, Sorgho H, Cook I, Muthuri S, Soo C, Mukomana F, Agongo G, Wandabwa C, Afolabi S, Oduro A, Tinto H, Wagner RG, Haregu T, Wade A, Kahn K, Norris SA, Crowther NJ, Tollman S, Sankoh O, Ramsay M; as members of AWI-Gen and the H3Africa Consortium. Stark regional and sex differences in the prevalence and awareness of hypertension: An H3Africa AWI-Gen study across 6 sites in Sub-Saharan Africa. Global Heart. 2017 Mar 13. pii: S2211-8160(17)30007-8. doi: 10.1016/j.gheart.2017.01.007

 

 22

Cisse M, Awandare GA, Soulama A, Tinto H, Hayette MP, Guiguemdé RT. (2017). Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso. Malaria Journal, 2017 Jan 23;16(1):38. doi: 10.1186/s12936-017-1695-1.

 

 23

Mavoko HM, Nabasumba C, da Luz RI, Tinto H, D'Alessandro U, Kambugu A, Baraka V, Rosanas-Urgell A, Lutumba P, Van Geertruyden JP. (2017). Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): A bicentre, open-label, phase 3, randomised controlled trial. Lancet Global Health. 2017 Jan;5(1):e60-e68. doi: 10.1016/S2214-109X(16)30236-4.

Copyright 2014 - CRUN | Clinical research Unit of Nanoro. All right reserves.

Top Desktop version